Aripiprazole
Abilify (Aripiprazole) - BMS
Official pharmaceutical site for this antipsychotic medication indicated for the treatment of schizophrenia.
Abilify Consumer Drug Info
Consumer FAQ in html format with a link to approved labeling in pdf format (requires Adobe Acrobat reader).
Aripiprazole (Abilify)
Patient information sheet provided by the U.S. Food and Drug Administration Center for Drug Evaluation and Research. Includes FDA Alerts.
Aripiprazole (Abilify): A Novel Atypical Antipsychotic
Article describes this medication's mode of action, side effects, and some early experiences using it in children with psychotic or bipolar illness.
Bristol's Brightest Day, Blackest Night
Forbes article about the U.S. FDA approval of Abilify discusses this drug's pharmacology and stated advantages compared with other schizophrenia medications.
MedlinePlus: Aripiprazole
Features information about dosage, usage, warnings, and side effects.
MedlinePlus: Aripiprazole (Systemic)
Features information about dosage, usage, warnings, and side effects.
Showing 20–8 of 8 results